Royal Society Open ScienceBioinformaticsPeer-reviewed journal article
Screening of anti-Acinetobacter baumannii phytochemicals, based on the potential inhibitory effect on OmpA and OmpW functions
Shahab ShahryariiD, Parvin MohammadnejadiD, Kambiz Akbari NoghabiiD
Abstract
Therapeutic options, including last-line or combined antibiotic therapies for multi-drug resistant (MDR) strains of Acinetobacter baumannii are ineffective. The outer membrane protein A (OmpA) and outer membrane protein W (OmpW) are two porins known for their different cellular functions. Identification of natural compounds with the potentials to block these putative porins can attenuate the growth of the bacteria and control the relating diseases. The current work aimed to screen a library of 384 phytochemicals according to their potentials to be used as a drug, and potentials to inhibit the function of OmpA and OmpW in A. baumannii. The phytocompounds were initially screened based on their physicochemical, absorption, distribution, metabolism, excretion, and toxicity (ADMET) drug-like properties. Afterward, the selected ligands were subjected to standard docking calculations against the predicted three-dimensional structure of OmpA and OmpW in A. baumannii. We identified three phytochemicals (isosakuranetin, aloe-emodin and pinocembrin) possessing appreciable binding affinity towards the selected binding pocket of OmpA and OmpW. Molecular dynamics (MD) simulation analysis confirmed the stability of the complexes. Amongst them, isosakuranetin was suggested as the best phytocompound for further in vitro and in vivo study.
- Citations
- 30
- FWCI
- 1.98
- Field percentile
- top 13%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A peptide targeting outer membrane protein A of Acinetobacter baumannii exhibits antibacterial activity by reducing bacterial pathogenicity
- Antimicrobial activity of a repurposed harmine-derived compound on extensively drug-resistant Acinetobacter baumannii clinical isolates
A. Breine, M. Van Gysel, … C. Van der Henst·bioRxiv·Jun 30, 2021
- Therapeutic Relevance of NLPA Lipoprotein to Combat Biofilm-Associated infection in Acinetobacter baumannii
Vahinipati U Brahma, Sharon Munagalasetty, Vasundhra Bhandari·bioRxiv·May 20, 2026
- A multidisciplinary approach towards identification of novel antibiotic scaffolds for Acinetobacter baumannii
S. P. Bhamidimarri, M. Zahn, … B. van den Berg·StructurePeer-reviewed·Feb 1, 2019
- Acinetobacter baumannii's Great Escape: How a Membrane Protein Interacts with Fibronectin to Evade Immunity.
Laurine Vasseur, Florent Barbault, Antonio Monari·Chemistry - A European JournalPeer-reviewed·Jul 25, 2025
- DcaP-Family Porins are Required for Carboxylic Acid Utilization and Infection in Acinetobacter baumannii
Hannah R. Noel, Nikita R. Kesav, … Lauren D. Palmer·bioRxiv·Jul 2, 2025